6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
ID: 36C77025Q0093Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/449198ddf8b748ff80a55db1b3672567/view
Timeline
  1. 1
    Posted Jan 3, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 3, 2025, 12:00 AM UTC
  3. 3
    Due Jan 10, 2025, 9:00 PM UTC
Description

The Department of Veterans Affairs is soliciting proposals for the procurement of Fexofenadine HCL 60MG (500CT) for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). Vendors are required to submit detailed quotes that include a signed SF1449 solicitation cover page, a completed pricing schedule, a valid wholesale distributor license, and OEM authorization for over-the-counter products, ensuring compliance with the Buy American Act and other regulatory standards. This pharmaceutical product is critical for treating allergies and must meet stringent quality and safety requirements, including a minimum shelf life of one year upon delivery. Proposals are due by January 10, 2025, at 3:00 PM CT, and interested vendors can contact Contract Specialist Jennifer D Coleman at jennifer.coleman4@va.gov for further information.

Point(s) of Contact
Jennifer ColemanContract Specialist
(913) 758-9934
Jennifer.Coleman4@va.gov
Files
Title
Posted
36C77025Q0093_1.docx
Jan 3, 2025, 7:05 PM UTC
The Department of Veterans Affairs (VA), through Network Contracting Office 15, is seeking bids for the procurement of Fexofenadine HCl 60mg medication to be delivered to the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The solicitation number is 36C77025Q0093, with a response deadline set for January 10, 2025, at 3 PM Central Time. The contract is categorized as a Small Business Set-Aside, and offers are to be submitted via email to the designated Contract Specialist, Jennifer Coleman. Interested vendors must comply with the Drug Supply Chain Security Act (DSCSA), submitting their state wholesale distributor license along with their quotes. Submissions should include a signed solicitation cover page, a price schedule in Excel format, and a Buy American Act (BAA) certificate indicating the country of origin for the products. The estimated issue date for the solicitation is January 3, 2025, and delivery is expected within ten days after receipt of the order. This presolicitation notice invites responsible sources to participate in meeting the ongoing pharmaceutical needs of veterans.
36C77025Q0093.docx
Jan 3, 2025, 8:05 PM UTC
The document pertains to a solicitation issued by the Department of Veterans Affairs for a pharmaceutical supply contract, specifically for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The requisition outlines a detailed request for offers (RFP), specifying requirements, pricing schedules, delivery protocols, and compliance clauses. The contract emphasizes the importance of providing pharmaceuticals that meet strict regulatory and quality standards, including barcoding and therapeutic equivalence. Offerors are instructed to submit detailed quotes, including pricing in Excel format and relevant legal documentation. Delivery logistics are crucial, mandating coordination with CMOP to adhere to operational hours and tracking procedures. The document incorporates various Federal Acquisition Regulation (FAR) clauses, underlining contractual obligations and compliance requirements for contractors serving federal entities. The content highlights the government's focus on efficient procurement processes, aiming to supply high-quality pharmaceuticals while ensuring adherence to legal and safety standards during the acquisition process.
S02 - Pricing Schedule Q0093 - FEXOFENADINE.xlsx
Jan 3, 2025, 8:05 PM UTC
The document outlines a Request for Quote (RFQ) from the CMOP Tucson facility, identified as RFQ 36C77025Q0093, for a specific pharmaceutical product, Fexofenadine HCL 60MG (500CT). Vendors must submit their proposals by January 10, 2025, at 3:00 PM CT, including a signed SF1449 solicitation cover page, a completed quote spreadsheet, a valid wholesale distributor license, and OEM authorization for OTC products. Additionally, a Buy American Act certificate is required. All submitted quotes must adhere to stipulations regarding expiration dates, ensuring that products have a minimum shelf life of one year upon delivery. Vendors are allowed to propose one quote only and must provide details in the comments section regarding any variations in quantities or expiration dates. The document emphasizes compliance with regulatory requirements and the procurement process for pharmaceuticals, reflecting the government's commitment to maintaining standards in sourcing medical supplies.
Lifecycle
Title
Type
6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
Currently viewing
Presolicitation
6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
Solicitation
Similar Opportunities
6505--Aprepitant Capsules
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Aprepitant capsules, a pharmaceutical product essential for various government health facilities, including those under the Department of Defense and Indian Health Service. Offerors are required to provide pricing for multiple line items covering a base year and four option years, adhering to specific conditions such as a 0.5% Cost Recovery Fee and compliance with the Drug Supply Chain Security Act (DSCSA). The contract emphasizes the importance of maintaining current Good Manufacturing Practices (cGMP) and ensuring proper labeling and packaging of the products. Interested contractors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details and must submit their proposals in accordance with the outlined requirements.
6505--Hydroxychloroquine SO4 Tablets
Buyer not available
The Department of Veterans Affairs is soliciting offers for the procurement of Hydroxychloroquine SO4 Tablets, specifically 200mg tablets, through its National Acquisition Center. The solicitation outlines the requirements for supply contracts, including compliance with Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), as well as the need for a unique National Drug Code (NDC) for each product. This procurement is crucial for ensuring a consistent supply of pharmaceuticals to government healthcare facilities, thereby maintaining availability and pricing stability. Interested contractors should note that the deadline for submitting offers has been extended to April 8, 2025, at 2:30 PM CDT, and can reach out to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further inquiries.
6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0196 770-25-3-801-0371 -National CMOP A1222 ACAMPROSATE TAB
Buyer not available
The Department of Veterans Affairs is seeking vendors to provide Acamprosate Calcium 333mg EC tablets under solicitation number 36C77025Q0196 for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement includes specific quantities of the pharmaceuticals, with a total of six different shipment requirements outlined, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to federal regulations regarding pharmaceutical distribution. This opportunity is critical for ensuring the availability of essential medications for veterans' healthcare, reflecting the VA's commitment to quality and regulatory compliance in its supply chain. Interested vendors must submit their quotes, including a signed Standard Form 1449, a detailed price schedule in Excel format, and a state wholesale distributor license by April 9, 2025, with the estimated award date set for April 14, 2025. For further inquiries, vendors can contact Michael W McAlhaney at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.
6505--Fludrocortisone Acetate Tablets (VA-25-00047932)
Buyer not available
The Department of Veterans Affairs is soliciting bids for the procurement of Fludrocortisone Acetate Tablets (0.1 MG) under the VA & DoD Pharmaceutical Prime Vendor Programs. Contractors are required to submit proposals that include pricing for a base year and four option years, adhering to specific guidelines such as a 0.5% Cost Recovery Fee and compliance with the Drug Supply Chain Security Act. This procurement is crucial for ensuring a consistent supply of essential pharmaceuticals to veterans, emphasizing the importance of Good Manufacturing Practices (cGMP) and the need for a unique National Drug Code (NDC) for each product offered. Interested contractors should contact Youlanda Duggar at youlanda.duggar@va.gov for further details and to ensure compliance with all submission requirements.
Fexofenadine HCL Follow On MOD P00002
Buyer not available
Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is seeking Fexofenadine HCL Follow On MOD P00001. Fexofenadine HCL is a drug used to relieve symptoms of seasonal allergies such as runny nose, sneezing, itchy or watery eyes, and itching of the nose or throat. This procurement is for NDC changes. For more information, please contact Catherine Gilbert at catherine.gilbert@dla.mil or 2157374778.
6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
6505--Perphenazine Tablets (VA-25-00037353)
Buyer not available
The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to supply specified quantities of the drug to both the VA and the Department of Defense (DoD) through their Pharmaceutical Prime Vendor (PPV) Programs, with a focus on service-disabled veteran-owned small businesses, women-owned small businesses, and HUBZone small businesses. The procurement is critical for ensuring a consistent supply of pharmaceutical products while adhering to regulatory requirements, including the Drug Supply Chain Security Act (DSCSA) and FDA Good Manufacturing Practices (cGMP). Interested offerors must contact Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov for further details, and proposals must include a 0.5% Cost Recovery Fee and a unique National Drug Code (NDC) for each product.
760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
Q517--Staffing Service Tucson
Buyer not available
The Department of Veterans Affairs is seeking proposals from Service-Disabled Veteran-Owned Small Businesses (SDVOSB) for staffing services at the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The contract requires the provision of pharmacists, pharmacy technicians, and shipper/packer services to support the processing of over 15 million prescriptions annually, with a minimum staffing level of 70 full-time equivalents (FTE) across various shifts. This procurement is critical for ensuring effective healthcare delivery to veterans, emphasizing compliance with federal regulations, including HIPAA, and maintaining high operational standards. Interested contractors must submit their proposals by the newly established deadline of July 23, 2024, and can direct inquiries to Contract Specialist Nicholas L. Schulte at nicholas.schulte1@va.gov or Christy Pendlay at Christy.Pendlay@va.gov.
Fexofenadine HCL Follow On
Buyer not available
Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is procuring Fexofenadine HCL Follow On. Fexofenadine HCL is typically used as an antihistamine to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching.